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Trypanosoma cruzi. a protozoan parasite, causes American trypanosomiasis or
Chagas' disease. The infective stage of this parasite resides in the hindgut of the
reduviid bug (family Reduviidae), which is both host and vector, and is transmitted to
the mammalian host through fecal material released during a blood meal. Chagas'
disease, an acute to chronic infection resulting in fever, malaise, and heart and liver
enlargement, is becoming a concern in the United States due to the large increase in
Latin American immigrants, and the lack of safe and effective therapeutic treatment
and vaccination. Another growing concern in the United States involves
environmental toxicants and their ability to act as immunosuppressants. Lead is of
particular interest because it is widespread in places such as soil, food, water, batteries,
paints, and plastics. Studies have shown lead exposure during bacterial and viral
infection causes decreases in antibody production, T cell recognition, and macrophage
activity—all of which result in decreased host resistance to infection. The present
study was conducted to determine the immunosuppressive effects of lead acetate in
C57B1/6 mice challenged with the Brazil strain of T\ cruzi. Mice were treated with
Vlll

lead acetate concentrations ranging from 0 to 1000 p.p.m. in their drinking water for
three weeks prior to infection. During the fourth week of the experiment, mice were
injected with lxlO 4 blood-form trypomastigotes (BFTs) of T\ cruzi and lead treatment
was continued. Food and water consumption was measured to monitor feeding
patterns and lead exposure during infection. Parasitemias were performed at fourteen
days post infection and continued at 3 and 4 day intervals throughout the study.
Parasite-specific antibody production was determined by an indirect enzyme-linked
immunosorbent assay (ELISA) using serum samples collected during high parasite
counts. Average daily food consumption showed no statistical differences between
lead-treatment groups of mice per replicate experiment. Average daily water
consumption and mean weight gain showed no statistical differences among groups in
replicates II and III; however, in replicate I significant differences were observed in
both variables between mice receiving 100 and 1000 p.p.m. lead acetate
concentrations. The highest mean peak parasitemias were observed in mice receiving
100 and 1000 p.p.m. lead acetate, though high lead acetate concentrations did not
appear to suppress T\ cruzi-specific antibody production. Although low mortality was
observed in lead-treated mice, the results of this study suggest that lead exposure does
enhance the susceptibility of mice to infection with T\ cruzi, resulting in high
parasitemias.

IX

INTRODUCTION
Toxicology
Toxicology has been defined by Newcombe (1992) as "the science dealing with
chemicals that cause disease." For a chemical to be classified as a toxicant, it must
enter the host organism through one of several exposure routes: dermal; oral;
inhalational; or intravenous. Exposure time of toxicants may vary from acute (four-six
hours) to chronic (three months to two years). There are many ways to classify a
toxic substance including primary target organ, use of substance, exposure time,
exposure route, physical state of substance, chemical qualities of substance, and
biochemical processes used to eliminate the substance. Pesticides, radiation, animal
toxins, and heavy metals are the toxicants which have been most studied to date
(Houston, W.E. 1994, pers. comm.). Heavy metals have become a particular concern
because many are found naturally. The effects of metals depend on several factors
including concentration, duration of exposure, species and sex of the host, and route of
exposure.

Immune Response Mechanisms
The immune system is complex and involves a variety of different cell types
which interact with foreign substances in a host organism. The defense mechanisms
1
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used by the host include innate immunity and acquired immunity. The innate immune
response involves the general defense mechanisms of a host including anatomic,
physiologic, endocytic and phagocytic, and inflammatory (Kuby, 1994). The primary
characteristics of acquired immunity are specificity, diversity, self/nonself recognition,
and immunological memory (Kuby, 1994). The host is able to mount a heightened
and more rapid response to a repeated exposure to antigen due to immunological
memory.
Cellular and humoral immunity are two mechanisms involved in acquired
immunity. The cellular response consists of those reactions that operate through the
specificity and direct activity of T lymphocytes, and manifest as either cell-mediated,
delayed-type hypersensitivity (DTH), tumor and allograft rejection, or allogeneic
disease (Kuby, 1994). Cell-mediated immunity involves the activity of CD8+ T
cytotoxic cells and occurs when the T cells respond to specific antigens. Delayed-type
hypersensitivity, a type IV hypersensitive response mediated by T cells, is a response
that occurs approximately two or three days after the T cell interacts with an antigen
and involves the release of particular cytokines, such as, interleukins 2 and 3, tumor
necrosis factor (3, and interferon y (Kuby, 1994). The DTH response is particularly
important in defending the host against bacterial and parasitic infections.
Humoral immunity functions by producing antibodies which are circulated
through the serum. There are five classes of immunoglobulin in humans, designated
IgM, IgG, IgA, IgE, IgD.

IgG and IgM classes of immunoglobulins are extremely

useful in defending the host against extracellular bacteria and exotoxin-producing
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bacteria due to their agglutinating properties and their ability to fix complement
(Kuby, 1994).
Lymphocytes are important in both acquired and innate immunity. One type of
lymphocyte, the T cell, arises from hematopoietic stem cells in the bone marrow and
completes its maturation in the thymus gland (Kuby, 1994). T cells divide and
become distinct as either helper, cytotoxic, or memory cells. The other type of
lymphocyte, the B cell, arises from stem cells in the bone marrow and remains in the
marrow until maturation. B cells produce antibodies and influence T cells by acting as
antigen-presenting cells. CD4+ T helper cells (class II major histocompatibility
complex (MHC)-restricted) recognize antigen-class II MHC complex on an antigenpresenting cell. T cell receptor (TcR) recognition involves the formation of a trimolecular complex (MHC + antigen + TcR) (Kuby, 1994). Once the complex is
bound the T helper cell is activated to secrete a variety of cytokines which stimulates
B lymphocytes to undergo clonal expansion. In this process, B cells divide repeatedly
and differentiate into plasma cells (antibody secreting) and memory cells (expressing
membrane-bound antibody) (Kuby, 1994). IgG and IgM class immunoglobulins
participate in the enhancement of phagocytosis, neutralization of toxicity, and
complement-mediated lysis (Caren, 1981; Kuby, 1994). CD8+ cytotoxic T cells (class
I MHC-restricted) destroy tumor cells and foreign cells upon contact. Memory T cells
are responsible for the enhanced recognition response to a specific foreign substance.
Most antigens require the participation of both T helper and B cells to stimulate an
antibody response.

Macrophages play a major role in the immune response as antigen processing
and antigen presenting cells. Macrophages are derived from monocytes, and both cell
types are actively phagocytic. Macrophages and monocytes process and present the
antigen in association with class 13 MHC molecules to CD4+ Th cells, secrete
cytokines, and respond in antibody-dependent cell-mediated cytotoxicity (Kuby, 1994).

Immunotoxicology
The field of immunotoxicology combines knowledge from immunology and
toxicology to determine the effects of toxicants on the immune system. As a
discipline, immunotoxicology involves the study of opposing effects of occupational,
inadvertent, or therapeutic exposure to drugs and environmental chemicals or
biological products on the immune system of living organisms (Exon, 1990). The
field of immunotoxicology was initiated in the 1970's when researchers began
investigating the immunotoxic potential of two environmental chemicals,
polychlorinated biphenyls (PBCs) and lead (Loblay and Neill, 1992). Through the
1970's and early 1980's, the number of studies increased and the international
awareness of immunotoxicology grew (Exon, 1990).
Immunotoxicants can be xenobiotic (pharmaceuticals, cosmetics, food
additives, agricultural chemicals, environmental pollutants, and natural toxins) or
biological products (enzymes, hormones, vaccines, allergen extracts, blood products,
monoclonal antibodies, interferons, interleukins, growth factors, and other cytokines)
(Loblay and Neill, 1992). There are three modes of action by which xenobiotics may
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induce immunosuppression: hormonal effects caused by xenobiotic-induced changes in
normally secreted hormone levels; chemically-induced functional defects of cells in the
immune response; and chemically induced depletion of responding cells (Faith et al.,
1980). Chemical induction, which results in a decreased number of responding cells
correlates with defects in cellular activation or initiation of suppressor cells (Faith et
al, 1980). When the responding cells are affected, lymphocytes may die, blockage of
lymphocyte maturation may occur, and there may be interference with lymphocyte
activity (Faith et al, 1980).
The immune system may respond to an immunotoxicant by suppression or
enhancement of reactions directed against the chemical or one of its metabolites.
Immunosuppression may result in increased susceptibility of the host to viral, bacterial,
fungal pathogens, or cancer (Vos, 1977). Immunosuppressive compounds are typically
drugs, alkylating agents, thiopurines, folic acid antagonists, pyrimidine nucleoside
analogues, some antibiotics, industrial chemicals, pesticides, and heavy metals (Vos,
1977; Koller, 1979). An immunosuppressive substance may act upon rapidly dividing
cells such as lymphocytes, hemopoietic, and reproductive cells (Vos, 1977). The
effects on the immune system are not selective and can impact the immune system
directly or indirectly.
One successful approach to determining if an environmental contaminant could
affect the immune system, thus enhancing susceptibility to infection, is to inject the
host with an LD50 dose of a bacterial or a viral pathogen during exposure to a toxicant
(Koller, 1979). An LD50 dose is lethal to 50 % of the individuals given that dose. In
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1971, Hemphill et al. studied the ability of lead to suppress host resistance to
Salmonella typhimurium. hypothesizing that exposure to low concentrations of lead
would cause mice to have decreased resistance to bacterial infection. Swiss-Webster
mice were exposed to subclinical doses (either 100 (ag or 200 jig) of lead nitrate for
thirty days (Hemphill et al., 1971). There were no overt clinical signs of toxicity
observed during the observation period, despite indications of enhanced susceptibility
to the bacteria. A Tenfold increase in mortality with an LD50 (10"4 7) of SL
typhimurium was observed in lead-treated mice relative to controls. Hemphill et al.
(1971) concluded there was a negative impact of lead exposure on the immune system,
causing decreased resistance of the host against SL typhimurium and resulting in high
mortality. It is known that lead has the ability to bind to proteins in vitro and possibly
in vivo. Hemphill et al. (1971) suggested the ability of lead to bind to various
complement proteins, involved in antigen-antibody interaction, may interfere with the
functional activity of the alternative and the classical complement pathways, thus
decreasing the resistance of the host to Jv typhimurium.
Prior to 1977, most of the studies involving lead focused on increased
susceptibility to infectious gram-negative bacteria containing endotoxins (Vos, 1977).
Seyle et al. (1966) studied the effects of lead on rats exposed to a bacterial endotoxin.
A greater sensitizing effect was observed when lead and Escherichia coli endotoxin
were given simultaneously (Seyle et al., 1966). In this case, susceptibility to
endotoxin was shown to increase approximately 100,000 times; when rats were treated
with 100 fag of K coli endotoxin, the death rate and histopathology was the same as
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when the rats were exposed to 1 ng of K coli and 5 mg/100 g body weight of lead (a
well tolerated dose).
The effects of methylmercury, tetraethyl lead, and sodium arsenite on the
humoral immune response of Swiss cross male mice also have been examined (Blakley
et al., 1980). This particular experiment lasted for three weeks, with groups of mice
receiving concentrations of between 0.5 and 10.0 p.p.m. of methylmercuiy, tetraethyl
lead, or sodium arsenite in their drinking water. The mice in this study did not show
signs of toxicity to either methylmercury, tetraethyl lead, or sodium arsenite; however,
maximum immunosuppression of antibody-producing cells and antibody production
was found in all metal concentrations of 0.5 and 1.0 p.p.m. and somewhat less
immunosuppression with 2.0 p.p.m. A dose-related effect on tissue-metal
concentrations was observed at all metal concentrations when the kidney and the liver
were analyzed (Blakley et al., 1980). High lead concentration exposure resulted in
high tissue-lead concentration. The authors of the study suggested that the mechanism
of suppression may have involved impairment of macrophage function or depression of
particular lymphocyte subpopulations (Blakley et al., 1980).
Koller et al. (1979) conducted a study to determine if lymphocytes obtained
from CBA mice treated with lead or cadmium would have an altered response to
mitogen stimulation. Twenty-five mice (group 1) were given 13, 130, or 1300 p.p.m.
lead acetate, and twenty-five mice (group 2) received 3, 30, or 300 p.p.m. cadmium
chloride in their drinking water for ten weeks. Selected animals in each group were
injected with Mycobacterium bovis (BCG). Neither lead nor cadmium had an
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observable effect on T lymphocyte proliferation induced by exposure to the mitogen
concanavalin A (Con A). Lead treatment did result in depression of the proliferative
response of lymphocytes to the mitogens lipopolysaccharide (LPS) and purified protein
derivative (PPD), while cadmium actually stimulated blastogenesis in response to these
mitogens (Koller et al., 1979).
Faith et al. (1979) investigated chronic, low concentration lead exposure on
Sprague Dawley rats. Newborn female rats were given 25 and 50 p.p.m. lead acetate
in their drinking water for seven weeks. The rats were mated with untreated males
and continued on the lead-treatment through gestation and lactation. Male and female
offspring were maintained on the same regimen as the mother, and between the ages
of 35 and 45 days, were studied for immunological effects. Second generation rats
showed no differences in growth rate and no clinical signs of toxicity were observed.
Both male and female offspring had significantly lowered thymic weights at birth in
each treatment condition relative to controls. Researchers found lead treatment
depressed the ability of the lymphocytes to respond to mitogen stimulation with
phytohaemagglutin-p (PHA) or Con A and delayed-type hypersensitivity to PPD
challenge. The decrease in thymic cell proliferation in response to Con A was not
significantly different among lead-treatment groups. T lymphocyte proliferation in
response to PHA or Con A demonstrated a statistically significant decrease in both
lead-treatment groups relative to controls. These results suggest that long-term
exposure to lead may lead to immunosuppression of cell-mediated and humoral
immune function (Faith et al., 1979).
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Koller (1973) analyzed the effects of lead, cadmium, and mercury on the
humoral antibody response in rabbits exposed to a viral pathogen. New Zealand
White male rabbits were exposed to 2500 p.p.m. lead acetate, 300 p.p.m. cadmium
chloride, or 10 p.p.m. mercuric chloride for 70 days. No clinical signs of toxicity
were observed. The animals were challenged with pseudorabies virus (Herpesviridae
family) on day 71, with a second dose day 78, and a third dose on day 85. Serum
samples were prepared on the same days for use in ELISA assays to determine
antibody production. The lead-treated rabbits showed an approximate tenfold decrease
in antibody production. Mean serum-antibody titers were significantly decreased in all
treatment metal groups relative to controls. Mercury-treated rabbits showed the least
decrease in antibody titers compared to other metal treatment groups. There also was
a significant decrease in the packed cell volume and body weight gain of the leadtreated groups, though no such decreases were observed in cadmium- or mercurytreated rabbits (Koller, 1973).
Koller and Kovacic (1974) studied Swiss-Webster mice exposed to 13.75,
137.5, or 1375 p.p.m. lead acetate concentrations in their drinking water for 56 days.
Mice were inoculated with sheep red blood cells (SRBC) and their antibody production
was measured. The results showed a decrease in antibody production and numbers of
B lymphocytes relative to controls (Koller and Kovacic, 1974). IgG antibody response
was low, suggesting that memory cells were affected by lead acetate exposure. The
longer the animals were exposed to lead, the greater the decrease of both IgM and IgG
antibody production. Koller and Kovacic (1974) suggested lead acetate decreased the
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number of antibody-producing cells, leading to a decrease in the level of circulating
antibodies, and that the reduction in antibody production is responsible for the
increased risk of bacterial or viral disease in animals with chronic exposure to lead.
Koller and Brauner (1977) also studied the effects of lead and cadmium
exposure on B lymphocytes in CBA/J mice. Twenty-five CBA/J mice exposed to 13,
130, or 1300 p.p.m. lead acetate or 3, 30, or 300 p.p.m. cadmium chloride in their
drinking water for 70 days. No toxic signs were observed. The number of
erythrocyte-antibody-complement (EAC) rosettes were significantly lower in the mice
treated with 130 or 1300 p.p.m. lead or 30 p.p.m. cadmium as compared to the control
group. Exposure to lead and cadmium was associated with decreased formation of
rosettes, thus accounting for the decrease in antibody response occurring during
primary immunity (Koller and Brauner, 1977). Koller and Brauner (1977) suggested
that, in this experiment, because the lymphocyte viability and percentage T and B cells
were common between treatment groups, the complement receptor site on the surface
of the B cell was altered by lead and cadmium exposure. A direct inhibition of B
cells due to lead and cadmium exposure represents an obvious danger to the health of
a host, as B cells produce antibodies (Koller and Brauner, 1977).
BDF, female mice were used to study the effects of lead acetate on
macrophage activity (Blakley and Archer, 1981). Concentrations of lead acetate
ranged from 50 to 1000 p.p.m. and were administered in drinking water for three
weeks. Suppression of macrophage activity by lead exposure was observed when
macrophage-dependent antigens, SRBC, or dinitrophenyl-Ficoll was used; however,
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when the macrophage-independent antigen R coli LPS was used, no such suppression
was seen (Blakley and Archer, 1981). There were no signs of lead toxicity expressed
by the mice. Results of this study indicated that lead exposure suppressed the immune
response by compromising early macrophage function. The specific effect has yet to
be identified but may involve recognition of the antigen, antigen processing, or
amplification of the immune response (Blakley and Archer, 1981).
Phagocytosis and oxidative metabolism of cadmium and lead by peritoneal
macrophages was studied by Hilbertz et al. (1986). Oxidative metabolism induced by
phorbol myristate acetate (PMA) solution was enhanced by exposure to both metals;
however, zymosan-induced oxidative metabolism was decreased significantly by
cadmium exposure (and to a lesser extent by lead exposure) within the first hour of
exposure (Hilbertz et al., 1986). After 20 hours, lead exposure suppressed oxidative
metabolism induced by zymosan and PMA along with the phagocytosis of latexparticles in a concentration-dependent manner. Lead exposure reduced cell viability
only slightly (Hilbertz et al., 1986). These results suggest that the enhancement of
PMA-induced oxidative metabolism in the first hour of treatment with lead or
cadmium results in increased release of toxic oxygen metabolites into the surrounding
environment of the cell, thus impairing the defense mechanisms of macrophages
(Hilbertz et al., 1986).
Because lead has been found to be an immunosuppressant, Sin and Woo (1992)
wanted to determine whether lead exerted a detrimental effect on phagocytic functions
under acute inflammatory conditions. Female Swiss albino mice were given 2000
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p.p.m. lead nitrate in their drinking water for three months. Two months after initial
lead exposure the mice were vaccinated with formalin-killed parasites, Trypanosoma
e van si. One month after immunization the mice were infected with live T\ evansi
parasites. The results suggested lead-treated mice were not immunologically protected
from T\ evansi infection after immunization. The total number of phagocytes in the
lead-treated mice was significantly reduced compared to controls, suggesting a
reduction in the total number of exudate leukocytes. This study also demonstrated
lead-treatment to be detrimental to the nonspecific immune response by decreasing the
chemotactic response of neutrophilic polymorphonuclear leukocytes (PMN) to
inflammation. Lead may affect mononuclear phagocytes as well, causing the host to
be more susceptible to infection (Sin and Woo, 1992).
Lawrence (1981) discussed the ability of heavy metals to reduce humoral
immunity, cell-mediated immunity, and lymphocyte division. However, Lawrence
(1981) describes lead and nickel demonstrating immunopotentiating effects by
enhancing the maturation of B cells into plaque-forming cells (PFC). This effect was
greater than the effect upon the development of mixed lymphocyte cultures (MLC)
(Lawrence, 1981). Lead exposure was shown to enhance the MLC response of CBA/J
spleen cells to C57B1/6 stimulators, thus the ability of lead exposure to enhance the
PFC response may be caused by the enhanced production of T helper cells (Lawrence,
1981). Lawrence demonstrated that T-dependent and T-independent responses were
equally enhanced by lead exposure. Immunopotentiating effects of lead and nickel
may be due to modulation of B cell, T cell, or macrophage functions (Lawrence,
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1981).
Previously heavy metals have been shown to decrease antibody production,
TcR recognition to antigen, and macrophage activity; however only recently metal
toxicity and autoimmune response has been examined. Kowolenko et al. (1992)
hypothesized that heavy metal toxicity may be due in part to autoimmunity. Heavy
metals have been shown to directly modulate lymphocyte function leading to enhanced
B and T cell activity which may result in autoimmunity (Kowolenko et al., 1992).
One particular heavy metal, lead, has been shown to affect the function of CD4+ T cell
subset which regulates all immune responses (McCabe and Lawrence, 1990). Lead
was also found to inhibit T helper 1 cell function but to enhance T helper 2 cell
function. These two subpopulations of cells (Th 1 and Th 2) function to regulate cellmediated and humoral immunity (Kowolenko et al., 1992). Heavy metals are also
believed to be inducers of allergic hypersensitivity (Kowolenko et al., 1992). Type I,
II, and III hypersensitivity responses involve the production of antibody, while type IV
involves a cell-mediated response. All hypersensitivity responses are activated when
lymphocytes are sensitized by internal or external factors (Kowolenko et al., 1992).
Toxicants can cause a direct effect on the immune system by changing the lymphocyte
subset ratio, changing the morphology of the immune tissue, reducing the total number
of immune cells, or by changing the function of the immune system with or without
the above alterations (Luster et al., 1984). Toxic substances may cause tissue damage
resulting in the release of sequestered antigens or an increased number of tissue
antigens, thereby stimulating the immune system and causing autoimmunity
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(Kowolenko et al, 1992). In addition, toxicants depress immune cells, causing an
increased incidence of infections and possibly an increase in autoimmune responses
(Kowolenko et al., 1992).

Immunoassays
Although a number of immunoassays have been developed during the last ten
years, only a few have been adapted to evaluate the effects of toxicants on the immune
system. Three main assays have been used to evaluate the humoral immune response:
the antibody-forming cell response to T-dependent SRBC antigens; the proliferative
response to B cell mitogen LPS; and the quantification of the number of B cells in the
spleen (White, 1992). Measurement of the antibody-forming cell response has proven
very useful, as it is a good indicator of general immunocompetence. Methods used to
determine antibody-forming cells include enzyme-linked immunospot, filter immunoplaque assay, and to measure antibody production enzyme-linked immunosorbent assay
(ELISA) is used. The antibody-forming cell assay is sufficient in recognizing
compounds which modulate the immune response because it is holistic in nature
(White, 1992). There are also a few assays which have been used to determine the
effects of toxicants on cell-mediated immunity: the mixed leukocyte response (MLR);
the spleen lymphocyte response to T lymphocyte mitogen Con A; the cytotoxic T
lymphocyte assay (CTL); and the delayed hypersensitivity response (DHR) to keyhole
limpet haemocyanin (KLH) (White, 1992). The National Toxicology Program (NTP)
also has selected assays to study natural killer (NK) cell functions and macrophage
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activity (White, 1992).

Lead
Lead, an inorganic heavy metal, is a naturally occurring element which has
been redistributed by humans. A large number of people and animals are exposed to
lead on a daily basis, as lead is found in air, soil, paint, plastic, water, food, products
of burnt coal, and batteries. Humans and animals are exposed to lead via inhalation
and ingestion (Faith et al, 1979). Lead poisoning has been documented when
contaminated foods and beverages were consumed, when plumbing fixtures made of
lead have been used in homes, and when cooking utensils containing lead were used to
prepare food (Faith et al, 1979). Because it causes extensive CNS damage (Goyer,
1991), lead poisoning is a major threat to the health of young children and infants. A
variety of studies also have shown that lead suppresses the immune system.
Depression of the activity of the immune system by lead exposure occurs at low
subclinical doses and is therefore considered to be deleterious to the health of animals
(Faith et al, 1979).
Koller (1980) suggested that studies should be conducted to determine how
contaminants affect the activity of B cells, T cells, macrophages, and the interaction of
these cells in both in vitro and in vivo conditions. Lead exposure is known to
suppress phagocytic function, thus reducing the immune response due to impairment of
antigen processing and presentation by macrophage (Exon, 1990). Lead exposure
has also been shown to affect the cell-mediated response. Faith et al (1979)
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demonstrated impairment of the delayed-type hypersensitivity response in Sprague
Dawley rats exposed to lead acetate. In an in vitro study of T-lymphocyte activity,
CBA/J and C57B1/6 mice infected with Listeria monocytogenes and treated with high
concentrations of lead acetate showed a slight reduction in T cell activity (Lawrence,
1981).

Chagas' disease
In 1907 Carlos Chagas located an area of Brazil, Minas Geraes, where thatched
roof houses were infested with blood sucking (haematophagus) bugs, Conorhinus
megistus. The bugs were examined and flagellated protozoa were found in their
hindguts. Flagellates could be found in the bloodstream 20-30 days after an individual
was bitten by the reduviid bug. The bugs were examined at the Institute Oswaldo
Cruz, thus the parasites were termed Trypanosoma cruzi (Minchin, 1910).
The causative agent of Chagas' disease is the flagellated protozoan,
Trypanosoma cruzi. which has a single nucleus and undergoes three life cycle stages:
(1) the intracellular amastigote stage, which is round and lacks a flagellum replicates
in the mammalian host; (2) the epimastigote stage, which possesses a juxtanuclear
kinetoplast and a flagellum replicates in the vector; and (3) the trypomastigote stage,
which possesses a flagellum and has a post-nuclear kinetoplast does not replicate
(Wendel and Gonzaga, 1993). Amastigotes are found in vertebrate macrophages,
muscle fibers, and within cells of the central nervous system (CNS). Epimastigotes
are seldom detected in the vertebrate bloodstream; however, this form is common in
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the foregut of the reduviid bug. Trypomastigotes are located in the vertebrate
bloodstream, lymph and cerebrospinal fluid, and in the invertebrate duodenum and
hindgut (Wendel and Gonzaga, 1993). Trypomastigotes are approximately 20 jam
long, may be short and thick or long and slender, and form a characteristic C or U
shape in bloodsmears (Markell et al., 1986).

Transmission
The trypomastigote is the infective stage of the parasite for humans. T. cruzi
parasites are introduced via fecal material into the bitten area when a reduviid bug
takes a blood meal. Infection occurs when infective trypomastigotes are rubbed into
the wound or eye, or cross the mucosa. Lymph fluid transports the parasites to the
lymph nodes. After the trypomastigote enters the bloodstream it invades macrophages
or other nucleated cells where it transforms into the amastigote stage and divides by
binary fission. The amastigote avoids degradation by escaping the phagosome and
entering the cytosol of the macrophage prior to lysosomal fusion. Amastigotes
transform back into trypomastigotes, which are released when the cell ruptures and are
free to invade other cells or enter the circulatory system. The trypomastigote can
independently penetrate nucleated cells or it may gain access by phagocytosis. The
organs most susceptible to infection are spleen, liver, lymph nodes, and muscles
(skeletal and cardiac). The infection also effects the nervous system, reproductive
system, intestine, Kupffer cells, reticuloendothelial cells, and bone marrow (reviewed
in Bogitsh and Cheng, 1990).
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T cruzi has several natural reservoirs including skunks, marmots, sloths, bats,
foxes, jaguars, ferrets, rabbits, mice, hamsters, marmosets, armadillos, raccoons,
opossums, monkeys, and squirrels (Wendel and Gonzaga, 1993). It has been shown
that birds and reptiles are resistant to T\ cruzi infection (Wendel and Gonzaga, 1993).
Chagas' disease via blood transfusions is relatively frequent (200 reported cases, many
go unreported) in Latin America. Infected individuals tend to live in low
socioeconomic areas where blood screening is not available. Even when screening
tests are performed on blood donor samples, T. cruzi has a phenomenal viability.
Whole blood infected with T\ cruzi can survive refrigeration for 18 days and withstand
freezing for 24 hours, indicating a high risk of transmission via blood transfusions.
All blood products, unless sterilized, may be infectious. The frequency of
transmission through blood transfusions depends on parasite strain, parasitemia levels
of donor blood, recipient's immune system, and quantity of blood transfused (Wendel
and Gonzaga, 1993). Tissues used for organ transplantation can also transmit T cruzi
infection (Wendel and Gonzaga, 1993).
Reports indicate congenital transmission is possible yet uncommon. Breast
feeding has also been shown to be a possible mode of transmission (Wendel and
Gonzaga, 1993).

Disease symptoms and stages
Chagas' disease is most common and most severe in children under five.
Symptoms occur predominantly in the central nervous system (CNS), and children may

19
develop meningoencephalitis and die within days. Infants experience fever,
lymphadenitis, hepatosplenomegaly, and anasarca (Markell et al., 1986).
Older children and adults typically have a milder, subacute, or chronic form of
the disease with no CNS complications (Markell et al, 1986). The acute stage ends in
a few weeks either in death (approximately 10% frequency) (Miles, 1983), full
recovery, or transition to the chronic stage.
Following infection, the parasites enter the subcutaneous tissue macrophages
where localized swelling occurs (chagoma). Facial and ocular edema is commonly
unilateral (Wendel and Gonzaga, 1993). The lesion reaches full size within several
days and slowly decreases size in two or three months (Markell et al., 1986).
Symptoms of infection appear four to fourteen days post inoculation. Parasites can be
microscopically detected on day 10 of infection and persist during the acute phase.
The symptoms during the acute stage of infection include fever, malaise, and
headaches. Hepatosplenomegaly and myocardial damage may occur; however, cardiac
involvement and gastrointestinal symptoms may not appear until many years following
infection (Bogitsh and Cheng, 1990). Other clinical observations include tremors,
seizures, meningitis, and lymphadenopathy (Wendel and Gonzaga, 1993). Patients
with symptomatic infections may exhibit signs and symptoms of congestive heart
failure (mainly in the right ventricle) but this condition is rare in patients under 25
years of age (Markell et al., 1986). In early chronic stages, the heart may be normal
in size or slightly larger; however, in late stages approximately 30% of infected
individuals develop severe cardiomegaly (Miles, 1983). Inflammation, fibrosis, and
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infiltration by lymphocytes, macrophages, and plasma cells all occur within cardiac
muscle.

Iminunoprotection of T. cruzi
Immunoprotective mechanisms for T\ cruzi infection involve both humoral
immunity and cell-mediated immunity. Immunoglobulin class IgG is the primary
antibody produced during the course of infection (Markell et al., 1986). Parasite lysis
is achieved by: antibody-dependent and complement-mediated mechanisms; natural
killer (NK) cells; and cytotoxic T lymphocytes (CTL). Activated macrophages,
neutrophils, and eosinophils also destroy trypomastigotes during cell-mediated
responses (Markell et al., 1986; Kuhn, 1989).

Research
Over the past 15 years, research has been conducted on the immune response
of lead-treated experimental animals challenged with bacterial and viral infections.
However, little research has been done on the effects of lead exposure during parasitic
infection. In the present study, the effect of lead acetate treatment during infection
with Trypanosoma cruzi was investigated.
The present study was designed to examine the effects of high lead acetate
concentrations on the humoral immune response of C57B1/6 female mice when
challenged with T\ cruzi. Same sexed animals were used in this study to eliminate
gender variability. C57B1/6 mice are not highly susceptible to the Brazil strain of T
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cruzi and normally live 46-180 days post infection with parasitemias peaking at 7.5 x
105 parasites/ml of blood (Grogl and Kuhn, 1985). C57B1/6 mice were chosen for this
study in order to better demonstrate whether lead acetate showed humoral
immunosuppressive qualities. The specific questions addressed in this study included:
1) What is the effect of lead acetate on parasitemia levels?; 2) What is the effect of
lead acetate on the mortality rate?; 3) How does lead acetate affect parasite-specific
antibody production?; and 4) Does exposure to lead acetate affect the growth rate of
mice infected with T. cruzi?

MATERIALS AND METHODS
Mice
Seventy-two C57B1/6 female mice were obtained at 5 weeks of age (Jackson
Laboratory, Bar Harbor, Maine) and acclimated for two weeks on deionized water and
Laboratory Rodent Chow (PMI Feeds, St. Louis, Missouri). Mice were then divided
into three replicate trials containing 24 mice, and each replicate consisted of four
experimental groups with six mice per group. The four experimental groups were
given the following lead acetate concentrations in their drinking water for three weeks
prior to infection: Group 1-0 p.p.m., Group 2-10 p.p.m., Group 3-100 p.p.m., and
Group 4-1000 p.p.m. After three weeks of lead exposure, mice received an
intraperitoneal injection of lxlO 4 blood-form trypomastigotes (BFTs) of Brazil strain
Trypanosoma cruzi, which is continuously maintained in the laboratory as a stock
infection in C3HeB/FeJ mice. Mice in replicates II and III were inoculated with a
different isolate of the same Brazil strain of T. cruzi as used for mice in replicate I.
Lead acetate (Sigma Chemical Company, St. Louis, Missouri), 0.002 g, was
dissolved in 2 L of deionized water to make a 1000 p.p.m. stock solution. The
remaining concentrations were diluted from the stock.
H 2 0 and food was provided ad libitum and levels were measured during the
study. At two week intervals, the weight (g) of each mouse was measured and
22
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recorded.

Preparation of T. cruzi antigen extract
A PSC3H murine fibroblast cell line infected with T\ cruzi trypomastigotes was
cultured in RPMI-1640 medium (Sigma) supplemented with 10% newborn calf serum
(Microbiological Associates, Walkersville, Maryland), 25 mM HEPES (Sigma), and
penicillin/streptomycin. Culture supernatants containing typomastigote stages were
collected and filtered through Whatman #1 filter paper. The filtered supernatant was
then certtrifuged for 30 minutes at 1800 x g. The pellet, which contains parasites, was
resuspended in 1 ml of Dulbecco's Phosphate Buffered Saline (DPBS), placed in a 1.7
ml Eppendorf tube (Fisher Scientific, Pittsburgh, Pennsylvania), and centrifuged for 15
minutes at 2000 x g. The pellets were resuspended two more times, combined and
resuspended in ice-cold DPBS containing 0.5% Triton X and 2 mM
phenylmethylsulfonyl fluoride (Sigma) and the suspension was transferred to a 15 ml
centrifuge tube and incubated for 30 minutes in an ice bath while being vortexed
periodically. The resulting suspension was spun at 8,000 rpm for 15 minutes to
remove insoluble material; the supernatant was collected. A Bio-Rad protein
determination assay was performed on the antigen extract using bovine serum albumin
as a standard. The antigen extract was diluted to a working concentration of 50 (ig/ml
in DPBS for use in an indirect enzyme linked immunosorbent assay (ELISA).

Preparation of murine plasma
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At two week intervals during the acute stage of infection (14-50 days), 4

of

tail vein blood was extracted from each of the 72 mice. Blood was transferred to 1.7
ml Eppendorf tubes, and 96 |il of DPBS were added to each sample. The solution was
mixed thoroughly then centrifuged at 5,000 rpm for 10 minutes. Plasma samples were
stored at -4° C until used in indirect ELISA assays.

Parasitemia
Parasite counts were conducted at 3 and 4 day intervals starting at day 14 post
infection. Four |il of tail vein blood was mixed with 96 |al DPBS in Eppendorf tubes,
constituting a 1/25 dilution. A hemacytometer (Fisher Scientific) was used to count
the parasites by placing approximately 20 |il of the cell suspension on the slide and
counting the parasites seen in the four large corner squares. The number of cells/ml of
blood was calculated using the equation: cells/ml = (avg. number/large square) *
104/ml * 1/dilution. Parasitemias were conducted until the levels declined to near
zero.
Mean peak parasitemias were calculated by determining the peak parasitemia
for each treatment group for each day analyzed. The three replicate experiments (I, II,
and III) were combined by calculating the mean peak of all mice receiving each lead
acetate concentration.

Indirect ELISA
Individual wells of 96 well microtiter plates (Falcon) were incubated with 100
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of a T\ cruzi culture cell antigen extract (50 |j.g/ml in DPBS). Plates were
incubated at room temperature overnight and then stored at -70° C until use. Thawed
plates were rinsed three times with fresh DPBS, then blotted dry. Wells were filled
with blocking solution (2.5% Carnation Instant Nonfat Dry Milk in DPBS) and
incubated for one hour at 37° C. After incubation, plates were rinsed three times and
blotted dry. One hundred ^xl of 1:25 diluted murine plasma was placed into the first
well of each row of the microtiter plate and a 2 x serial dilution of the plasma in
DPBS was performed across the plate. Each sample of murine plasma was tested in
duplicate rows. Plates were covered and incubated for two hours at 37° C. After
incubation, plates were washed four times with DPBS. After the fourth wash wells
were filled with DPBS and incubated for 5 minutes. Once plates were blotted dry, 50
|al of horseradish peroxidase-conjugated goat anti-mouse immunoglobulin (Sigma)
diluted 1:1000 in blocking solution was added to each well. Plates were covered and
incubated for one hour at 37° C. After incubation the plates were washed four times
with DPBS and blotted dry with paper towels. Fifty microliters of substrate solution
were added to each well and incubated for 15 minutes at 37° C. Substrate solution
was prepared by dissolving 30 mg O-phenylenediamine dihydrochloride (OPD; Sigma)
in 10 ml Tris Citrate Buffer (0.3 M Tris base in 0.5% Triton X-100 pH to 6.0 with
anhydrous citric acid). Eight |il of 0.025% H 2 0 2 was added to the solution just prior
to adding the substrate to the wells. Plates were analyzed on a Model 550 microplate
reader (Bio-Rad) at an absorbance of 490 nm. Antibody titers were determined
according to the following equation: titer = highest dilution of the test serum in which

the absorbance is > .05 and > the mean control absorbance +2 standard deviations.

Statistical analysis
Data were analyzed using SYSTAT@ 5.0 (SYSTAT, Inc., 1992). Analysis of
variance (ANOVA) was used to test for differences in parasitemia counts among leadtreated groups within individual replicate experiments. To determine which treatment
groups differed significantly, a pairwise comparison using Tukey's HSD Multiple
Comparison Test was employed (SYSTAT Inc., 1992).
To evaluate significant correlation between parasitemia and antibody production
a Spearman correlation coefficient was used (Wilkinson, 1992).
To examine potential changes in food and water consumption over time, a
linear regression analysis of slopes was conducted. Slopes of zero suggest each leadtreatment group per cage maintained the same diet patterns throughout the study. An
analysis of covariance (ANCOVA) was used to test for significance among treatment
groups' diet patterns in each replicate experiment. The assumption of homogeneity of
slopes was by Multivariate General Linear Hypothesis (MGLH) and when satisfied
ANCOVA, was employed to test for significance among lead-treated groups. To
determine which treatment groups differed significantly a pairwise comparison using
Tukey's HSD Multiple Comparison Test was employed (SYSTAT Inc., 1992).
Testing for significant changes in mouse weight was conducted by using
ANCOVA. MGLH and Tukey's HSD test were used as described above.

RESULTS
Mortality
Mortality was low during the course of the present study; however, one mouse
in replicate I receiving 1000 p.p.m. lead acetate concentrations died on day 63 post
infection.

Mouse weights
In all three replicate experiments weight changed significantly over time; I(3=0.019, p<0.001, II-p=0.025, p<0.001, and III-|3=0.025, p<0.001 (Figure 1).
The assumption of homogeneity of slopes was satisfied for all lead-treatment
groups in replicate I (F3 ,=0.773, p=0.510). Tests of intercept differences among
treatment groups were significant (F3 ,=3.766, p=0.012). Pairwise comparisons of all
lead-treatment groups indicated that mice receiving 100 p.p.m. lead acetate weighed
significantly more than mice receiving 1000 p.p.m. (p=0.009) (Figure la).
The assumption of homogeneity of slopes was satisfied for all lead-treatment
groups in replicates II and III (F3,=0.953, p=0.418 and F 31 =0.354, p=0.787).
However, ANCOVA analysis for intercept differences in replicates II and III were
nonsignificant (F31=0.984, p=0.403 and F31=2.371, p=0.076, respectively) (Figures lb
and lc).
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Water and food consumption
Replicate by treatment combinations showed 10 of 12 regressions of average
daily water consumption over time were nonsignificant. Mice receiving 10 p.p.m.
(p=0.023) and 1000 p.p.m. (p=0.001) lead acetate concentrations in replicate I showed
significant decrease in water consumption over time (Figure 2a). However, when data
from all treatments are pooled ANCOVA showed there were significant decreases in
water consumption over time in all three replicates (I-F3 ,=16.750, p<0.001, IIF3 ,=10.522, p=0.002, ni-F 3 ,=8.006, p=0.006) (Figure 2). Nevertheless, average daily
water consumption among groups in each of the three replicates showed homogeneity
of slopes (F3,=1.573, p=0.201;F3 ,=9.596, p=0.898 and F 3 ,=4.425, p=0.940,
respectively). ANCOVA analysis showed significant differences among treatment
groups in replicate I (F3,=4.672, p=0.004). Mice receiving 100 p.p.m. lead acetate
concentrations drank significantly more water on average than did mice receiving 10
or 1000 p.p.m. lead acetate concentrations (p=0.038 and p=0.004, respectively) (Figure
2a). There were no statistical differences in among treatment groups in replicates II
and III (F3,,=1.075, p=0.364; F3 ,=0.020, p=0.996) (Figure 2c).
Replicate by treatment combinations showed 11 of 12 regressions of average
daily food consumption over time were nonsignificant. One slope from Group 4-1000
p.p.m. (p=0.022) in replicate I showed significant decrease in food consumption over
time (Figure. 3 a). However, when data from all treatments are pooled ANCOVA
showed there were significant decreases in food consumption over time in replicates I
and III (I-p=0.007 and III-p=0.001) (Figures 3a and 3c). The average daily food
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consumption in replicates I, II, and III showed homogeneity of slopes among treatment
groups (F31=0.393, p=0.758), (F3,=0.004, p=1.000) and (F31=0.035, p=0.991);
however, ANCOVA showed no statistical differences among lead-treatment groups (IF3 ,=2.114, p=0.114, II-F3,=0.436, p=0.728, and IH-F3 ,=0.463, p=0.709) (Figure 3).

Parasitemia
Overall mean peak parasitemias of each treatment group receiving lead acetate
are as follows: 0 p.p.m. lead acetate (infected control mice)-6.49 x 106 parasites/ml
blood; 10 p.p.m. lead acetate-9.61 x 106 parasites/ml blood; 100 p.p.m. lead acetate1.31 x 107 parasites/ml blood (twofold higher than infected control mice); and 1000
p.p.m. lead acetate-3.62 x 107 parasites/ml blood (sixfold higher than infected control
mice) (Figure 4).
The highest numbers of circulating blood-form trypomastigotes in all replicates
were observed in lead-treated mice receiving 100 and 1000 p.p.m. lead acetate
concentrations (Figure 5). Replicate I showed extremely high parasitemias (7.1 x
107 parasites/ml of blood) on day 39 of infection in mice receiving 1000 p.p.m. lead
acetate (Figure 5a). An analysis of variance of parasitemias from day 39 post
infection was highly significant (F3 ,=30.470, p<0.001); and HSD test showed Group 41000 p.p.m. had significantly higher parasitemias than Groups 1-0 p.p.m. (p<0.001), 210 p.p.m. (p<0.001), or 3-100 p.p.m. (p<0.001) (Figure 5a).
The highest peak parasitemia in replicate II was 9 x 106 parasites/ml of blood
observed on day 28 of infection in mice receiving 100 p.p.m. lead acetate (Figure 5b).
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Mice receiving 1000 p.p.m. lead acetate in replicate II showed two peaks; on day 21
of infection, mice had an average of 6.0 x 106 parasites/ml of blood, and on day 28 the
average was 6.5 x 106 parasites/ml of blood (Figure 5b). An analysis of variance
showed no statistical differences among lead-treatment groups on day 21 (F3>1=1.515,
p=0.241); however, parasite levels on day 28 differed significantly (F31=5.263,
p=0.008), as Group 3 showed significantly higher parasitemias than Group 1 (p=0.004)
(Figure 5b).
Mice receiving 100 p.p.m. lead acetate in replicate III showed two peaks in
parasitemias. On day 14 of infection, mice had an average of 1.4 x 107 parasites/ml of
blood, and on day 21 the average was 1.8 x 107 parasites/ml of blood (Figure 5c).
Mice receiving 1000 p.p.m. lead acetate concentrations in replicate HI showed their
peak parasitemia (1.8 x 107 parasites/ml of blood) on day 14 of infection (Figure 5c).
An analysis of variance of parasitemias on day 14 was highly significant (F3 j=5.849,
p=0.005); Group 4 had significantly higher parasitemias than Group 1 (p=0.003)
(Figure 5c). By contrast, on day 21 post infection, (F31=5.797, p=0.005) showed
Group 1 had significantly higher parasitemias than Group 4 (p=0.004) based on
ANOVA and HSD tests (Figure 5c).

Parasite-specific antibody levels
The parasite-specific antibody production did not show an obvious relationship
between high lead acetate concentrations (100 and 1000 p.p.m.) and decreased
antibody production throughout infection in serum samples diluted 1:25 (Figure 6).
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This dilution was chosen for analysis to demonstrate antibody production at the lowest
dilution factor. Spearman correlation coefficient testing showed there was not a
significant correlation between antibody production and parasitemia (p=0.252).
Parasite-specific antibody production in mice receiving 100 and 1000 p.p.m. lead
acetate concentrations from replicate I was high on day 32 of infection and low on
days 18 and 46 of infection (Figure 6a). Infected control mice receiving 0 p.p.m. lead
acetate showed their peak anti-T\ cruzi antibody production on day 46 post infection
(Figure 6 a).
Parasite-specific antibody production in mice receiving 100 p.p.m. lead acetate
from replicate II was highest on days 21 and 51 of infection and low on day 35
(Figure 6b). Mice receiving 1000 p.p.m. lead acetate in replicate II showed low
antibody production on days 21 and 35 of infection and high production on day 51
(Figure 6b). Infected control mice receiving 0 p.p.m. lead acetate showed their peak
anti-T\ cruzi antibody production on day 51 post infection (Figure 6b).
In replicate III the parasite-specific antibody production in mice receiving 100
and 1000 p.p.m. lead acetate was highest on day 41 of infection and lowest on day 14
(Figure 6c). Infected control mice treated with 0 p.p.m. lead acetate showed their peak
anti-T\ cruzi antibody production on day 30 post infection (Figure 6c). Anti-H cruzi
antibody titers for all replicate experiments are shown in Table 1.
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Table 1. The titers of anti-T.cruzi antibodies in mice receiving 0, 10, 100, and 1000
p.p.m. lead acetate concentrations in a) Replicate I, b) Replicate II, and c) Replicate
III.

a.

lead acetate
concentrations
0 p.p.m.
10 p.p.m.
100 p.p.m.
1000 p.p.m.

b.
lead acetate
concentrations
0 p.p.m.
10 p.p.m.
100 p.p.m.
1000 p.p.m.

day 18

day 32

day 46

1:25600
1:1600
1:6400
1:800

1:800
1:800
1:800
1:1600

1:400
1:6400
1:3200
1:6400

day 21

day 35

day 51

1:400
1:800
1:800
1:100

1:50
1:50
1:1600
1:800

1:1600
1:800
1:1600
1:800

day 14

day 30

day 41

1:400
1:400
1:400
1:800

1:6400
1:51200
1:1600
1:800

1:3200
1:1600
1:3200
1:1600

c.

lead acetate
concentrations
0 p.p.m.
10 p.p.m.
100 p.p.m.
1000 p.p.m.
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FIGURE 1. Average weights of mice measured over the course of the study before
and after lead exposure and T. cruzi infection in a) Replicate I, b) Replicate II, and c)
Replicate III. Results are presented ± 1 SE bar to suggest significance among
treatment groups.
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FIGURE 2. Linear regression analysis of average daily water consumption per cage
measured over the course of the experiment in a) Replicate I, b) Replicate II, and c)
Replicate III.
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FIGURE 3. Linear regression analysis of average daily food consumption per cage
measured over the course of the experiment in a) Replicate I, b) Replicate II, and c)
Replicate III.
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FIGURE 4. Mean peak parasitemias ± 1 SE of mice receiving 0, 10, 100, and 1000
p.p.m. lead acetate concentrations. The peak parasitemia was determined for each
treatment group for each day analyzed and an average was calculated. All three
replicate experiments were combined to obtain an overall mean peak parasitemia for
each lead acetate concentration (n=18 for all groups).
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FIGURE 5. Mean parasitemias per ml of blood from mice receiving 0, 10, 100, and
1000 p.p.m. lead acetate concentrations during infection with T. cruzi. Data are
expressed logarithmically as the average number of parasites per ml of blood in a)
Replicate I, b) Replicate II, and c) Replicate III. (*) represents days analyzed by
ANOVA.
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FIGURE 6. Parasite-specific antibody levels in mice exposed to 0, 10, 100, and 1000
p.p.m. lead acetate concentrations measured from pooled serum samples in a)
Replicate I, b) Replicate n , and c) Replicate 1H. Data presented represent absorbances
of serum samples diluted 1:25 and read at 490 nm. For each lead acetate
concentration n=6 for all replicates. NMS-normal mouse serum (control) (n=2).
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DISCUSSION
The results of the present research confirm previous studies which have
suggested that lead acetate possesses immunosuppressive qualities which may increase
host susceptibility to infectious disease. However, this research project is the first that
has evaluated the effect of exposure to lead acetate during experimental Chagas'
disease.
The results of the present study suggest exposure to high lead acetate
concentrations does increase the susceptibility of C57B1/6 mice challenged with the
Brazil strain of Trypanosoma cruzi. The greatest impact of high lead acetate exposure
was on numbers of circulating blood-form trypomastigotes (BFTs). C57B1/6 mice
infected with the Brazil strain of T. cruzi normally exhibit only moderate parasitemias
and a limited degree of histopathology (Rowland et al., 1992; Sun and Tarleton, 1993).
However, in the present study mice exposed to 100 and 1000 p.p.m. lead acetate
experienced extremely high numbers of circulating BFTs, which is generally regarded
as a direct indication of extensive tissue parasitism (Lima et al., 1995) and disease
severity. Rowland et cd. (1992) reported that pathopermissive mouse strains (strains
exhibiting a high degree of histopathology) have a much higher parasite load than
pathoresistant strains. The high parasite loads observed in lead-treated mice in the
present study suggest that lead-acetate may suppress the immune response to T\ cruzi.
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Tarleton (1990) demonstrated C57B1/6 mice immunosuppressed (depleted of CD8+ T
cells) prior to infection with T\ cruzi had higher parasitemias and increased disease
severity as compared to nonsuppressed control mice. Furthermore, immunosuppressed
individuals usually experience increased parasitemias, localized tissue parasites,
increased mortality, and increased severity of symptoms of Chagas' disease (Markell et
al, 1986; Calabrese et al, 1991).
Highest observed numbers of circulating BFTs were detected in mice receiving
100 and 1000 p.p.m. lead acetate concentrations in all three replicate experiments.
Mean peak parasitemias calculated from mice receiving a lead acetate concentration of
1000 p.p.m. (3.62 x 107 parasites/ml of blood) were sixfold higher than in 0 p.p.m.
lead acetate-treated mice (6.49 x 106 parasites/ml of blood) (Figure 4). Also, mean
peak parasitemias calculated from mice receiving 1000 p.p.m. lead acetate showed no
overlap of SE bars when compared to other treatment groups (Figure 4). No statistical
analysis was conducted on mean peak parasitemia data because different isolates were
used in replicates II and in, and parasitemia counts were not conducted on the same
days post infection. However, these results strongly suggest there is a dose dependent
effect of lead acetate resulting in increasing numbers of circulating BFTs in treated
mice.
Mice receiving 1000 p.p.m. lead acetate concentrations in replicate experiment
I showed a peak of 7.1 x 107 parasites/ml of blood on day 39 post infection which was
374 times greater than observed circulating BFTs in mice receiving 0 p.p.m. lead
acetate (1.9 x 105 parasites/ml of blood) (Figure 5). In replicate experiment II, mice
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receiving 100 p.p.m. lead acetate had two times more parasites/ml of blood on day 28
post infection (9.0 x 106) than that observed in mice receiving 0 p.p.m. (3.8 x 10®
parasites/ml of blood) (Figure 5). In replicate experiment IH, on day 14 post infection,
mice exposed to 1000 p.p.m. lead acetate had three times more circulating BFTs than
that observed in 0 p.p.m. lead-treated mice; however, on day 21 post infection, a peak
of 2.7 x 106 parasites/ml of blood in mice treated with 1000 p.p.m. lead acetate
concentrations was two times lower than that observed in mice receiving 0 p.p.m. lead
acetate (5.5 x 106 parasites/ml of blood) (Figure 5). All of the above results were
significantly different.
A previous study by Grogl and Kuhn (1985) compared the course of T\ cruzi
infection in relatively resistant C57B1/6 mice to that in C3H(He) mice, which are
highly susceptible to infection. Both strains of mice were inoculated with 1 x 103 BFT
of X. cruzi. It was reported that C3H(He) mice developed higher parasitemias than
C57B1/6 mice and that parasite numbers increased faster in C3H(He) mice. C3H(He)
mice died with high parasitemias (1.6 x 106 parasites/ml of blood) by day 24 or 25
post infection, whereas C57B1/6 mice survived from 46-180 days post infection.
C57B1/6 mice had peak parasitemias ranging from 5.0 x 105 to 9.0 x 105 parasites/ml
of blood. In the present study, mice in the control group (0 p.p.m. lead acetate) had a
mean peak parasitemia of 6.49 x 106 parasites/ml of blood. Observed numbers of
circulating BFTs in the present study may have been higher than those described by
Grogl and Kuhn (1985) because a tenfold greater parasite density was used for
inoculation.
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The high parasitemias observed in the present study suggest that lead-treated
C57B1/6 mice are more susceptible to T. cruzi infection. However, despite the
pronounced effect of high lead acetate concentrations on parasitemias, no increase in
mortality was observed. The question of why the animals survived up to 275 days
post infection with chronic exposure to high concentrations of lead acetate and high
parasitemias still remains unanswered. The effects of lead exposure on parasites are
unknown but lead may play an important role in altering the pathogenicity of the
parasite.
Immediately following the peak parasitemias in all three replicate experiments,
there was a sharp decrease observed in parasite counts. Antibody-dependent
complement-mediated lysis of trypomastigotes may be responsible for this rapid
decline. Despite severe immunosuppression observed during the acute stage of
Chagas' disease, it is well known that the parasite-specific antibodies produced during
the course of infection have a protective effect and demonstrate lytic activity against
the parasite (Leguizamon et al, 1991).
To examine the effects of lead exposure on the humoral immune response to T
cruzi. parasite-specific antibodies were measured during the course of infection. In
contrast to previous studies (Koller and Kovacic, 1974; Blakley et al, 1980) which
suggested that lead salts suppress antibody production, in this study all three replicate
experiments showed no obvious pattern between high lead acetate exposure and
lowered parasite-specific antibody production (Figure 6).
The results from replicate experiment I suggest highest levels of anti-T cruzi
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antibodies are being produced in mice receiving 100 and 1000 p.p.m. lead acetate just
prior to peak parasitemias (Figures 6 and 5, respectively). In replicates II and III,
highest levels of anti-T. cruzi antibodies in mice receiving 100 and 1000 p.p.m. lead
acetate were observed between 20 to 27 days after the peak of circulating BFTs
(Figure 6 and 5, respectively). Although, extremely high numbers of parasites were
observed in the present study there was no significant correlation between parasitemias
and antibody production. This result is in contrast to a previous study by Bennett
(1995) which demonstrated that parasitemias had a significantly positive correlation
with levels of anti-T cruzi antibodies in C3HeB/FeJ mice.
The results from the present study suggest lead acetate exposure time (21 days)
prior to T\ cruzi infection may not be long enough to cause decreased antibody
production in this less susceptible mouse strain subsequent to infection. In previous
studies in which decreased B-cell and antibody production was seen, experimental
animals were exposed to lead salts for 21 (Blakley et al., 1980), 49 (Faith et al., 1979),
56 (Koller and Kovacic, 1974), or 70 days (Koller, 1973; Koller and Brauner, 1977)
prior to antigen exposure. In the present study, anti-T cruzi antibody levels were not
measured late in infection (after 51 days post infection) and after chronic lead acetate
exposure. It is possible that a decrease in parasite-specific antibody production might
have been observed in later stages of the infection.
In a previous study by Grogl and Kuhn (1985), parasite-specific antibody
production was measured in C3H(He) mice and C57B1/6 mice during T\ cruzi
infection. This study showed C57B1/6 mice produced two times more anti-T\ cruzi

antibodies than C3H(He) mice. Immunoglobulin IgG, which is the primary antibody
produced during the course of T. cruzi infection, peaked on days 20 and 48 for
C3H(He) and C57B1/6 mice, respectively. Immunoglobulin IgM, peaked on day 20
and days 25 and 40 for C3H(He) and C57B1/6 mice, respectively. The authors
concluded that the high titer of anti-T. cruzi antibody in C57B1/6 mice was correlated
with their increased resistance to T\ cruzi infection (Grogl and Kuhn, 1985). Parasitespecific antibody production was highest on days 25, 40, and 48 post infection in
C57B1/6 mice (Grogl and Kuhn, 1985); therefore, supporting the results from the
present study which show an increase in antibody production on days 46 and 51 post
infection in replicates II and III, respectively.
Daily water and food consumption from each treatment group was measured
periodically throughout the study. After conducting a regression analysis on the data,
all slopes were shown to be negative, demonstrating a significant decrease in both
water and food consumption over time. Replicate by treatment combinations show
most lead-treatment groups had comparable decreases in water and food consumption,
therefore, suggesting mice per cage received similar amounts of water and food and
appropriate lead acetate concentrations. The observed decrease in water and food
consumption for all lead-treated groups of mice was likely due to the progressive
decrease in activity which was observed in mice infected with T\ cruzi. When data
from all treatments were pooled, 100 p.p.m. lead-treated mice drank significantly more
water than either Groups 2 (10 p.p.m.) or 4 (1000 p.p.m.) in replicate experiment I.
No significance in among lead-treated groups was observed in replicates II and IE.
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Results from Blakley and Archer (1981) and Blakley et al. (1980) also demonstrated
that water consumption in lead-treated mice measured over 3 weeks was not negatively
impacted by lead exposure.
Individual mouse weights were measured during the course of the study. In
replicate I, 100 p.p.m. lead acetate-treated mice weighed significantly more than mice
treated with 1000 p.p.m. lead acetate concentrations (Figure 1); however, no statistical
differences were observed among lead-treated groups in replicates II or HI. Mice in
replicate I receiving 100 p.p.m. may have weighed more because they drank
significantly more water than mice receiving 1000 p.p.m. (Figure 2). A noticeable
drop in the weight of mice receiving 1000 p.p.m. occurred between days 50 and 181 in
replicate H. Such a large decline in weight could be due to a temporary water loss in
the mice. However, the long interval between weight measurements makes it difficult
to interpret this result. In all three replicate experiments mice reached a plateau in
weight between days 50 and 60, suggesting individual growth rates were similar
among groups. These results are supported by the studies of Blakley et al. (1980) and
Blakley and Archer (1981) who showed there was no significant effect of lead
treatment on weight gain of Swiss cross mice or BDF, mice, respectively. Similarly
Sin and Woo (1992) reported that mean body weights of lead-treated Swiss albino
mice were not significantly different when compared to the control group. However,
one study by Koller (1973) showed New Zealand White rabbits exposed to 2500
p.p.m. lead acetate concentrations weighed significantly less than non-lead-treated
control rabbits.
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Mice were observed for signs of Chagas' disease and lead toxicity. Late in
infection 100 and 1000 p.p.m. lead acetate-treated mice became lethargic and
characteristic "humped backs" were observed along with weakened hind legs.
Toxicological signs observed were predominantly in mice treated with 100 and 1000
p.p.m. lead acetate which included hair loss and what was thought to be neurological
damage. The only observed mortality in the study was one mouse (in replicate I)
receiving 1000 p.p.m. lead acetate which died on day 63 post infection with low body
weight and obvious signs of Chagas' disease.
The results from the present study support previous studies which have
suggested that exposure to lead increases susceptibility to infectious agents (Hemphill
et al., 1971; Roller, 1973; Koller and Kovacic, 1974; Lawrence, 1981; and Sin and
Woo, 1992). C57B1/6 mice exposed to 100 and 1000 p.p.m. lead acetate
concentrations had mean peak parasitemias which were significantly higher when
compared to control mice and respectively, nineteen times and fifty-two times higher
than peak parasitemias of non-1 ead-treated, T\ cruzi infected, C57B1/6 mice observed
by Grogl and Kuhn (1985). Tissue levels of parasites and tissue destruction also
would be expected to be greater in mice with higher parasitemias, however,
histological studies will be necessary to confirm this prediction.
It will be important for future studies to determine the effects of lead acetate
exposure on CD4+ T helper and CD8+ T cytotoxic activity during T\ cruzi infection.
Faith et al. (1979) demonstrated exposure to lead salts had a negative impact on cellmediated immunity by decreasing T-cell proliferation. Lead has also been shown to

47
affect CD4+ T-cell function (McCabe and Lawrence, 1990) and inhibit Th 1
subpopulation function (Kowolenko et al., 1992).
As a follow-up to the present study, the laboratory will evaluate the effects of
lead acetate exposure in C3H(He) mice, which are highly susceptible to challenge with
1\ cruzi. This project will evaluate the effect of lead exposure on parasitemia and
mortality, evaluate the effects of lead exposure and T cruzi on cardiac and skeletal
muscle, liver, and kidney tissues, and evaluate water and weight changes of the leadtreated mice when infected with T cruzi.
Since 1970 many natural and synthetic substances have been shown to alter the
immune response and cause increased susceptibility to disease. With the rapid
progression of technology, it is important to be cognizant of the continuous work of
pharmaceutical companies (producing "newer and better" drugs) and chemical
companies (producing pesticides, synthetic fibers, etc.) as we approach the 21st century.
Due to such environmental health concerns, the past 20 years have been important in
evaluating environmental contaminants and toxicants which may have a negative
impact on the immune response therefore increasing susceptibility to infectious agents.
However, little research has been done to evaluate the effects of environmental
toxicants during parasitic infection. The topic of parasitic disease receives little
attention in the U. S., however, an estimated one billion of the world's population is
currently suffering from parasitic infection (Goodman, 1994). Furthermore, infectious
and parasitic diseases account for more than half the total burden of morbidity and
mortality in Sub-Saharan Africa, India, and much of Asia (Evans and Jamison, 1994).

48
Therefore, in light of the results of the present study, future studies should be designed
to further evaluate the effect of environmental toxicants, such as lead, during parasitic
infection.
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